Elliptic Laboratories ASA (OSL:ELABS)

Elliptic Laboratories ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	59.02	43.06	76.39	115.58	178.22	218.15
Cash & Short-Term Investments	59.02	43.06	76.39	115.58	178.22	218.15
Cash Growth	3.63%	-43.63%	-33.91%	-35.15%	-18.30%	118.76%
Accounts Receivable	78.81	81	110.94	60.61	40.5	29.03
Other Receivables	11.59	6.7	6.59	6.36	5.65	17.7
Receivables	90.41	87.7	117.52	66.97	46.15	46.72
Prepaid Expenses	-	1.42	1.54	3.09	1.25	0.08
Other Current Assets	0	-	-	-	-	-
Total Current Assets	149.43	132.18	195.45	185.64	225.62	264.95
Property, Plant & Equipment	12.16	12.41	16.66	19.91	2.26	2.79
Other Intangible Assets	69.05	71.45	66.25	55.63	47.57	36.56
Long-Term Deferred Tax Assets	-	-	75.42	78.17	68.84	62.53
Other Long-Term Assets	4.6	5.62	7.25	8.86	5.04	4.52
Total Assets	235.23	221.66	361.03	348.2	349.32	371.36

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.01	2	1.3	3.86	1.67	3.03
Accrued Expenses	8.04	18.56	15.03	13.08	9.33	8.42
Current Portion of Long-Term Debt	-	-	2	4	4	4
Current Portion of Leases	5.99	4.8	6.63	3.99	2.18	2.61
Other Current Liabilities	-	-0	-	0	-	-
Total Current Liabilities	17.04	25.36	24.96	24.93	17.18	18.06
Long-Term Debt	-	-	-	2	6	10
Long-Term Leases	7.07	8.31	10.73	15.87	0.52	0.53
Other Long-Term Liabilities	0	0	-	-0	-	0
Total Liabilities	24.11	33.67	35.69	42.8	23.7	28.59

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.26	1.05	1.05	1.05	1.04	1.04
Additional Paid-In Capital	415.67	359.96	359.83	355	345.52	342.55
Comprehensive Income & Other	-205.81	-173.01	-35.54	-50.65	-20.93	-0.81
Shareholders' Equity	211.13	188	325.34	305.4	325.62	342.77
Total Liabilities & Equity	235.23	221.66	361.03	348.2	349.32	371.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.05	13.11	19.35	25.86	12.71	17.14
Net Cash (Debt)	45.97	29.95	57.04	89.72	165.51	201.01
Net Cash Growth	8.43%	-47.49%	-36.43%	-45.79%	-17.66%	162.69%
Net Cash Per Share	0.40	0.28	0.51	0.86	1.59	2.04
Filing Date Shares Outstanding	126.34	105.29	105.27	104.84	104.07	103.84
Total Common Shares Outstanding	126.34	105.29	105.27	104.84	104.07	103.84
Working Capital	132.39	106.82	170.49	160.72	208.44	246.89
Book Value Per Share	1.67	1.79	3.09	2.91	3.13	3.30
Tangible Book Value	142.07	116.54	259.09	249.78	278.05	306.21
Tangible Book Value Per Share	1.12	1.11	2.46	2.38	2.67	2.95
Machinery	0.55	0.55	0.51	0.51	-	-
Order Backlog	-	32	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error